PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 561.00
-9.00 (-1.58%)
At close: Jul 31, 2026
PeopleBio Market Cap
PeopleBio has a market cap or net worth of 13.61 billion as of October 8, 2026. It is the 41,577th most valuable company in the world and the 2,564th biggest in South Korea. Its market cap has decreased by 73.43% in one year.
Market Cap
13.61B
Enterprise Value
24.03B
Revenue
3.84B
Global Rank
Country Rank
#2,564 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since October 19, 2020, PeopleBio's market cap has decreased from 127.63B to 13.61B, a decrease of -89.34%. That is a compound annual growth rate of -32.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 13.61B | -39.86% |
| Dec 30, 2025 | 22.63B | -64.95% |
| Dec 30, 2024 | 64.57B | -0.15% |
| Dec 28, 2023 | 64.67B | -65.14% |
| Dec 29, 2022 | 185.49B | 1.48% |
| Dec 30, 2021 | 182.78B | -36.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 186.48B |
| GC Medical Science | 100.64B |
| GENINUS | 81.54B |
| Inventera | 76.93B |
| Protia | 75.99B |
| Cytogen | 71.00B |
| HLB Panagene | 62.15B |
| GeneMatrix | 38.16B |